⋮
0
0
Sofosbuvir di Gilead per il trattamento dell'epatite C raggiunge l'endpoint primario nel quarto studio cardine di Fase III
Showing live article 673 of 40001 in channel 7572583
Article Details:
Author:
Language: Italian
Channel Number: 7572583
Article Number: 673
Date: February 19, 2013, 10:55 am
URL: http://www.informazione.it/c/F596422A-4336-4862-AACC-9F30DC045333/Sofosbuvir-di-Gilead-per-il-trattamento-dell-epatite-C-raggiunge-l-endpoint-primario-nel-quarto-studio-cardine-di-Fase-III
GUID: http://www.informazione.it/c/F596422A-4336-4862-AACC-9F30DC045333/Sofosbuvir-di-Gilead-per-il-trattamento-dell-epatite-C-raggiunge-l-endpoint-primario-nel-quarto-studio-cardine-di-Fase-III
←
$
..going to article 673
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL